Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hyaluronic acid-dependent extracellular matrix scaffolding refers to the process and structural phenomenon where hyaluronic acid (HA), a major natural glycosaminoglycan of the extracellular matrix, forms the backbone or primary component of biomaterial scaffolds used in tissue engineering and regenerative medicine. These scaffolds can be created as hydrogels, sponges, or fibrous matrices and are often designed to mimic the natural ECM environment, supporting cell adhesion, migration, and 3D tissue architecture. HA interacts with cell receptors (notably CD44) to regulate cellular processes such as proliferation, differentiation, and stemness, and these scaffolds are widely used in research and clinical applications for wound healing, cartilage regeneration, and as cancer models in vitro. As a "target," the term is imprecise: it represents an engineered or biological structure/material rather than a discrete molecular entity typically targeted by drugs.
Provides a physical 3D environment conducive to cell survival, differentiation, and tissue formation. Interacts with cell surface receptors such as CD44, triggering downstream pathways that regulate adhesion, migration, and proliferation. Serves as a reservoir for growth factors and cytokines within the ECM. Supports cell-matrix signaling critical for tissue morphogenesis and regeneration.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyaluronic acid-dependent extracellular matrix scaffolding.